These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21256570)

  • 21. The Influence of Practice Structure on Urologists' Treatment of Men With Low-Risk Prostate Cancer.
    Mitchell JM; Gresenz CR
    Med Care; 2022 Sep; 60(9):665-672. PubMed ID: 35880758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence-based guidelines in lower urinary tract symptoms secondary to benign prostatic hyperplasia and variation in care.
    Strope SA
    Curr Opin Urol; 2018 May; 28(3):262-266. PubMed ID: 29601306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of symptomatic BPH in France: who is treated and how?
    Lukacs B
    Eur Urol; 1999; 36 Suppl 3():14-20. PubMed ID: 10559626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. US patterns of care for urodynamic evaluation for BPH.
    Sze C; Zhang TR; Dreyfuss L; DeMeo G; Thorogood SL; Chughtai B; Te AE; Lee RK; Hu JC
    Neurourol Urodyn; 2023 Sep; 42(7):1563-1568. PubMed ID: 37395472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Korean urologist's view of practice patterns in diagnosis and management of benign prostatic hyperplasia: a nationwide survey.
    Oh CY; Lee SH; Yoo SJ; Chung BH
    Yonsei Med J; 2010 Mar; 51(2):248-52. PubMed ID: 20191018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management.
    Lerner LB; McVary KT; Barry MJ; Bixler BR; Dahm P; Das AK; Gandhi MC; Kaplan SA; Kohler TS; Martin L; Parsons JK; Roehrborn CG; Stoffel JT; Welliver C; Wilt TJ
    J Urol; 2021 Oct; 206(4):806-817. PubMed ID: 34384237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The urologist's view of male overactive bladder: discrepancy between reality and belief in practical setting.
    Lee SH; Kim DK; Kim JC; Lee KS; Lee JG; Park CH; Hong SJ; Kim CS; Park JK; Chung BH
    Yonsei Med J; 2010 May; 51(3):432-7. PubMed ID: 20376898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minimally invasive therapy for benign prostatic hyperplasia: practice patterns in Minnesota.
    Ercole B; Lee C; Best S; Fallon E; Skenazy J; Monga M
    J Endourol; 2005 Mar; 19(2):159-62. PubMed ID: 15798410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urologists' attitudes to sexual complications of LUTS/BPH treatments.
    Giona S; Ganguly I; Muir G
    World J Urol; 2018 Sep; 36(9):1449-1453. PubMed ID: 29680951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The symptom questionnaire for benign prostatic hyperplasia: an ambiguous indicator for an ambiguous disease.
    Stoevelaar HJ; van de Beek C; Nijs HG; Casparie AF; McDonnell J; Janknegt RA
    Br J Urol; 1996 Feb; 77(2):181-5. PubMed ID: 8800881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of medical management of overactive bladder (OAB) and benign prostatic hyperplasia (BPH) in the United States.
    Anger JT; Goldman HB; Luo X; Carlsson MO; Chapman D; Zou KH; Russell D; Ntanios F; Esinduy CB; Clemens JQ
    Neurourol Urodyn; 2018 Jan; 37(1):213-222. PubMed ID: 28455944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benign prostatic hyperplasia evaluation, treatment and association with sexual dysfunction: practice patterns according to physician specialty.
    Seftel AD; Rosen RC; Rosenberg MT; Sadovsky R
    Int J Clin Pract; 2008 Apr; 62(4):614-22. PubMed ID: 18266709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. National trends in the use of PSA, urinalysis, and digital rectal exam for evaluation of lower urinary tract symptoms in men.
    Doolin J; Reese ZA; Mukamal KJ
    World J Urol; 2021 Mar; 39(3):855-860. PubMed ID: 32448971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the United States.
    Taub DA; Wei JT
    Curr Urol Rep; 2006 Jul; 7(4):272-81. PubMed ID: 16930498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The agreement among urological experts on the diagnostic management of patients with common urological problems.
    Hansen MV; Zdanowski A
    Br J Urol; 1997 Nov; 80(5):787-92. PubMed ID: 9393304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urologist Practice Structure and Spending for Prostate Cancer Care.
    Modi PK; Herrel LA; Kaufman SR; Yan P; Borza T; Skolarus TA; Schroeck FR; Hollenbeck BK; Shahinian VB
    Urology; 2019 Aug; 130():65-71. PubMed ID: 31029672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative assessment of attitudes and expectations: Iranian patients versus urologists in the management of benign prostatic hyperplasia.
    Hosseini J; Alinejad Khorram A; Abedi AR; Hosseini MA; Fayaz M
    BMC Urol; 2024 Oct; 24(1):219. PubMed ID: 39379872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lower urinary tract symptoms suggestive of benign prostatic obstruction: what are the current practice patterns?
    McNicholas TA
    Eur Urol; 2001; 39 Suppl 3():26-30. PubMed ID: 11275739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and management of benign prostatic hyperplasia in primary care.
    Tanguay S; Awde M; Brock G; Casey R; Kozak J; Lee J; Nickel JC; Saad F
    Can Urol Assoc J; 2009 Jun; 3(3 Suppl 2):S92-S100. PubMed ID: 19543429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment choice for benign prostatic hyperplasia: a matter of urologist preference?
    Stoevelaar HJ; Van de Beek C; Casparie AF; McDonnell J; Nijs HG
    J Urol; 1999 Jan; 161(1):133-8. PubMed ID: 10037385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.